McIlrath & Eck’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ELAT
EC
WAM
McIlrath & Eck's ELAT Position: Q4 2022 in Review
McIlrath & Eck sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 2,000 shares — an estimated $42K sold.
McIlrath & Eck first reported a position in ELAT in Q1 2022 and held it in 2 quarters. The position peaked at $42K in Q3 2022. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.
- McIlrath & Eck reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
- McIlrath & Eck sold 2,000 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $42K.
- McIlrath & Eck first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2022 and held it in 2 quarters.
- McIlrath & Eck's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $42K in Q3 2022.
- 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.
Based on McIlrath & Eck's 13F filing for Q4 2022, filed 15 Feb 2023.